IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 193 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Leukocyte telomere length in Hispanic schizophrenia patients under treatment with olanzapine
Nancy Monroy-Jaramillo,Yaneth RodrÝguez-Agudelo,Luis Carlos Avi˝a-Cervantes,David L. Roberts,Dawn I. Velligan,Consuelo Walss-Bass
Journal of Psychiatric Research.2017;90()26
[DOI]
2Prevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India
Sandeep Grover,Munish Aggarwal,Subho Chakrabarti,Alakananda Dutt,Ajit Avasthi,Parmanand Kulhara,Nidhi Malhotra,Mansi Somaiya,Nidhi Chauhan
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2012;36(1)141
[DOI]
3Metabolic syndrome in antipsychotic na´ve patients with schizophrenia: pooled analysis of data from three Indian studies
Sandeep Grover,Naresh Nebhinani,Ramachandran Padmavati,Rakesh K Chadda,Srinivasan Tirupati,Abhishek Pallava
Early Intervention in Psychiatry.2015;9(5)357
[DOI]
4Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India
Sandeep Grover,Naresh Nebhinani,Subho Chakrabarti,Ajit Avasthi,Parmanand Kulhara,Debasish Basu,Surendra Kumar Mattoo,Savita Malhotra
Nordic Journal of Psychiatry.2014;68(1)72
[DOI]
5Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile andátreatment outcomes for clients on clozapine
Dominiek Coates,Patricia Woodford,Oliver Higgins,Deborah Grover
International Journal of Mental Health Nursing.2018;27(1)303
[DOI]
6A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia
Nidhi Malhotra,Parmanand Kulhara,Subho Chakrabarti,Sandeep Grover
Journal of Affective Disorders.2013;150(2)653
[DOI]
7A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia
Sandeep Grover,Harsh Garekar,Anisha Agarwal
Journal of Affective Disorders.2019;150(2)109
[DOI]
8Mental Health Nurses' Knowledge of Clozapine
Sujatha Sanjeevi,Angela Cocoman
Issues in Mental Health Nursing.2021;42(3)291
[DOI]
9Prevalence of metabolic syndrome in patients with schizophrenia in India
Sandeep Grover,Munish Aggarwal,Alakananda Dutt,Subho Chakrabarti,Ajit Avasthi,Parmanand Kulhara,Mansi Somaiya,Nidhi Malhotra,Nidhi Chauhan
Psychiatry Research.2012;200(2-3)1035
[DOI]
10Prescription practices and attitude of psychiatrists towards clozapine: A survey of psychiatrists from India
Sandeep Grover,Srinivas Balachander,Subho Chakarabarti,Ajit Avasthi
Asian Journal of Psychiatry.2015;18(2-3)57
[DOI]
11Does the Starting of Clozapine Influence Coprescription of Other Medications?
Sandeep Grover,Chandrima Naskar,Subho Chakrabarti
Journal of Clinical Psychopharmacology.2021;41(2)148
[DOI]
12Metabolic syndrome in antipsychotic na´ve patients diagnosed with schizophrenia
Sandeep Grover,Naresh Nebhinani,Subho Chakrabarti,Preeti Parakh,Deepak Ghormode
Early Intervention in Psychiatry.2012;6(3)326
[DOI]
13Effectiveness of clozapine on quality of life and functioning in patients with treatment-resistant schizophrenia
Meha Verma,Sandeep Grover,Subho Chakrabarti
Nordic Journal of Psychiatry.2021;75(2)135
[DOI]
14A meta-analysis of cardio-metabolic abnormalities in drug na´ve, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort,Martien Wampers,Alex J. Mitchell,Christoph U. Correll,Amber De Herdt,Michel Probst,Marc De Hert
World Psychiatry.2013;12(3)240
[DOI]
15Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus
Sandeep Grover,Meha Verma,Subho Chakrabarti
Journal of Clinical Psychopharmacology.2020;40(3)276
[DOI]
16Cost of the Illness of Treatment-Resistant Schizophrenia
Meha Verma,Sandeep Grover,Subho Chakrabarti
Journal of Clinical Psychopharmacology.2021;41(1)36
[DOI]
17Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
Marius H. Sneller,Nini de Boer,Sophie Everaars,Max Schuurmans,Sinan Guloksuz,Wiepke Cahn,Jurjen J. Luykx
Frontiers in Psychiatry.2021;12(1)36
[DOI]
18Effect of clozapine on psychological outcomes of caregivers of patients with treatment resistant schizophrenia
Meha Verma,Sandeep Grover,Subho Chakrabarti
Nordic Journal of Psychiatry.2021;75(2)118
[DOI]
19Effect of clozapine on psychological outcomes of caregivers of patients with treatment resistant schizophrenia
Parmanand Kulhara,Sandeep Grover,Natasha Kate
Nordic Journal of Psychiatry.2015;75(2)173
[DOI]
20Relationship of metabolic syndrome and neurocognitive deficits in patients with schizophrenia
Sandeep Grover,Padmavati R,Swapnajeet Sahoo,Subhashini Gopal,Ritu Nehra,Arthi Ganesh,Vijaya Raghavan,Anoop Sankaranarayan
Psychiatry Research.2019;278(2)56
[DOI]
21Metabolic syndrome in drug na´ve patients with substance use disorder
Manish Bathla,Manpreet Singh,Shazia Anjum,Parmanand Kulhara,Satyarth Jangli
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017;11(3)167
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow